What's in Janssen-Cilag, S.A.'s pipeline?

Janssen-Cilag, S.A. has 6 drugs in our index: 2 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Janssen-Cilag, S.A.'s portfolio?

Top competitors by shared drug class: GlaxoSmithKline, Ain Shams University, Balmoral Medical company, Alza Corporation, DE, USA, Archimedes Development Ltd.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/janssen-cilag-s-a.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Janssen-Cilag, S.A. — Portfolio Competitive Intelligence Brief

Janssen-Cilag, S.A. pipeline: 2 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 2 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
antipsychotics	antipsychotics	marketed			Neuroscience
Fentanyl-TTS	Fentanyl-TTS	marketed	Opioid analgesic	Mu (μ) opioid receptor	Pain Management
Gynoclin V	Gynoclin V	phase 3	Lincosamide antibiotic	Bacterial ribosome (50S subunit)	Infectious Disease / Gynecology
Vagitrol V	Vagitrol V	phase 3	proton pump inhibitor	H+/K+ ATPase	Gastrointestinal

Therapeutic area mix

Gastroenterology · 1
Gastrointestinal · 1
Infectious Disease / Gynecology · 1
Neuroscience · 1
Pain Management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

GlaxoSmithKline · 2 shared drug classes
Ain Shams University · 1 shared drug class
Balmoral Medical company · 1 shared drug class
Alza Corporation, DE, USA · 1 shared drug class
Archimedes Development Ltd · 1 shared drug class
Asbjørn Mohr Drewes · 1 shared drug class
Ajay Wasan, MD, Msc · 1 shared drug class
AdventHealth · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Janssen-Cilag, S.A.:

Cite this brief

Drug Landscape (2026). Janssen-Cilag, S.A. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/janssen-cilag-s-a. Accessed 2026-05-16.